Elder partners Gnosis for marketing anti-arthritis drugs

New Delhi, Dec 19 (UNI) Elder Pharmaceuticals Ltd today said, it has entered into a licensing agreement with Italy-based Gnosis for marketing and distribution of an anti-arthritis products in the country.

''We have entered into a licensing agreement with research oriented biotech company Gnosis S p A for marketing and distribution of an anti-arthritis product, S-Adenosyl-L-Methionine Disulphate p-Toluensulfonate (SAMe) in India,'' a company statement said.

UNI